Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
The grant opportunity invites new applications for Centers for Collaborative Research focused on Fragile X and FMR1-Associated Conditions. The goal is to better understand why individuals with these conditions show different symptoms or respond differently to treatments. Each center should focus on a key theme related to this variability, using multidisciplinary teams applying precision medici…
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
National Institutes of Health
-
DoW Neurofibromatosis Synergistic Idea Award
Defense Health Agency Contracting Activity - DHACA
-
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
National Institutes of Health
-
DoW Neurofibromatosis Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
-
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers